» Articles » PMID: 22892755

Progression of Cutaneous Melanoma: Implications for Treatment

Overview
Specialty Oncology
Date 2012 Aug 16
PMID 22892755
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The survival rates of melanoma, like any type of cancer, become worse with advancing stage. Spectrum theory is most consistent with the progression of melanoma from the primary site to the in-transit locations, regional or sentinel lymph nodes and beyond to the distant sites. Therefore, early diagnosis and surgical treatment before its spread is the most effective treatment. Recently, new approaches have revolutionized the diagnosis and treatment of melanoma. Genomic profiling and sequencing will form the basis for molecular taxonomy for more accurate subgrouping of melanoma patients in the future. New insights of molecular mechanisms of metastasis are summarized in this review article. Sentinel lymph node biopsy has become a standard of care for staging primary melanoma without the need for a more morbid complete regional lymph node dissection. With recent developments in molecular biology and genomics, novel molecular targeted therapy is being developed through clinical trials.

Citing Articles

Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway.

Qi X, Chen Y, Liu S, Liu L, Yu Z, Yin L Pharm Biol. 2023; 61(1):696-709.

PMID: 37092313 PMC: 10128503. DOI: 10.1080/13880209.2023.2200787.


The ampulla of Vater: A potential target for metastatic melanoma?.

Armany D, Gosal P, Adams S J Surg Case Rep. 2023; 2023(1):rjac621.

PMID: 36685125 PMC: 9848047. DOI: 10.1093/jscr/rjac621.


3D Bioprinting: An Enabling Technology to Understand Melanoma.

Fernandes S, Vyas C, Lim P, Pereira R, Viros A, Bartolo P Cancers (Basel). 2022; 14(14).

PMID: 35884596 PMC: 9318274. DOI: 10.3390/cancers14143535.


Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4.

Wolff D, Deng Z, Bianchi-Smiraglia A, Foley C, Han Z, Wang X Cell Chem Biol. 2022; 29(6):970-984.e6.

PMID: 35148834 PMC: 9620470. DOI: 10.1016/j.chembiol.2022.01.007.


Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.

Khan N, Mir M, Qian L, Baloch M, Khan M, Rehman A J Adv Res. 2022; 36:223-247.

PMID: 35127174 PMC: 8799916. DOI: 10.1016/j.jare.2021.06.014.


References
1.
Starz H, Balda B, Kramer K, Buchels H, Wang H . A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001; 91(11):2110-21. View

2.
Mortarini R, Gismondi A, Maggioni A, Santoni A, Herlyn M, Anichini A . Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res. 1995; 55(20):4702-10. View

3.
van Akkooi A, de Wilt J, Verhoef C, Schmitz P, van Geel A, Eggermont A . Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol. 2006; 17(10):1578-85. DOI: 10.1093/annonc/mdl176. View

4.
Mastrangelo M, Bellet R, Berkelhammer J, Clark Jr W . Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Cancer. 1975; 36(4):1305-8. DOI: 10.1002/1097-0142(197510)36:4<1305::aid-cncr2820360417>3.0.co;2-#. View

5.
Bachter D, Balda B, Vogt H, Buchels H . Primary therapy of malignant melanomas: sentinel lymphadenectomy. Int J Dermatol. 1998; 37(4):278-82. DOI: 10.1046/j.1365-4362.1998.00358.x. View